Close
Smartlab Europe
Inizio Ignite

Press Releases

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19....

Vibalogics announces collaboration to provide additional clinical trial material for covid-19 vaccine candidate

Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, announced that it will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical...

Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials

As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs. The alternative would be to suspend the trial and...

Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more...

Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of...

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19. Sterling will be manufacturing the active pharmaceutical ingredient (API) with the finished product being manufactured and supplied...

Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test

Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration approved its SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system. With the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »